Navigation Links
GlaxoSmithKline Recognizes University of Michigan's Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
Date:8/19/2007

New Award and Fellowship Supported by Multi-Year $1.3 Million Grant to the

ASCO Foundation

PHILADELPHIA, Aug. 16 /PRNewswire/ -- Daniel F. Hayes, MD, a University of Michigan oncologist and cancer researcher whose work in clinical and laboratory studies has advanced the management of breast cancer worldwide, was named today as the first winner of the annual Gianni Bonadonna Breast Cancer Award. Supported by a multi-year grant of more than $1.3 million from GlaxoSmithKline Oncology (GSK), the award will be presented by the American Society of Clinical Oncology (ASCO) and The ASCO Foundation at the Breast Cancer Symposium in San Francisco on September 7, 2007.

"GSK is honored to sponsor this award which is being presented to Dr. Daniel Hayes, a dedicated researcher who has been at the forefront of individualized breast cancer therapy," said Paolo Paoletti, MD, Senior Vice President of the Oncology Medicine Development Center at GlaxoSmithKline. "His contributions to the field of oncology have had an important impact on our knowledge about monitoring and managing the disease, and his findings have translated into real-world benefits for patients."

Dr. Hayes, who is Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center, is a widely recognized expert in breast cancer clinical research, particularly with new hormonal and chemotherapeutic treatments. He and his colleagues published the first reports on the CA15-3 blood test, currently used worldwide to evaluate breast cancer patients. Dr. Hayes' more recent research focuses on pharmacogenomics, and understanding the key role genes play in chemotherapy treatment.

The new award and an accompanying fellowship were created in honor of one of the giants of modern-day medical oncology, Dr. Gianni Bonadonna, of the Instituto Nazionale Tumori in Milan, Italy. Dr. Bonadonna was responsible for ground-breaking research i
'/>"/>

SOURCE GlaxoSmithKline

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3

Related biology technology :

1. GenTel acquires GlaxoSmithKline chip platform
2. Fermentation Cell Culture: University Style
3. Fueling our economy with the University of Wisconsin
4. CIO Leadership Series: Ed Meachen, University of Wisconsin System
5. University, business leaders convene in Wausau
6. University of South Florida expands GE Healthcare relationship
7. State and university form network for entrepreneurial outreach
8. University center offers speed boost to manufacturers
9. Building the modern public-purpose university should be UW Systems goal
10. University Research Park to add 20 incubator suites
11. University Research Park forms ties with German tech center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)... EDMONTON, Sept. 4 / BioMS ...e treatment of multiple sclerosis (MS), today,anno...of the United States,has granted fast track design...8298), for the treatment of secondary progressive ... evaluated in a U.S. pivotal phase III trial,name...
(Date:9/4/2008)...-FirstCall/ -- Repligen Corporation,(Nasdaq: RGEN...1.125 million,in research grants to support the de...a. The grants are comprised of $1 million from the... from the Friedreich,s,Ataxia Research Foundation ...he grants will further the development, characteri...
(Date:9/4/2008)...RNewswire/ -- Thomson Reuters, the,world,s leading...and,professionals, announced today that the Nation... of scientists worldwide using BIOMARKERcenter, th...ligence to provide,pharmaceutical, biotechnology, ...ework for assessing and tracking a potential bioma...
(Date:9/3/2008)...Full Year Guidance, SHENZHEN, China, Sept. 3 /Xin...national Limited (NYSE: MR ), a leading developer...ldwide today announced its selected,unaudited fina..., 2008.,During the quarter, Mindray successfully c...ent monitoring business. The financial results,rep...
Breaking Biology Technology:BioMS Medical's lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA 2BioMS Medical's lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA 3BioMS Medical's lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA 4Repligen Receives Research Grants to Support Friedreich's Ataxia Development Program 2Repligen Receives Research Grants to Support Friedreich's Ataxia Development Program 3Repligen Receives Research Grants to Support Friedreich's Ataxia Development Program 4Repligen Receives Research Grants to Support Friedreich's Ataxia Development Program 5The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters 2The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters 3Mindray Medical International Announces Second Quarter 2008 Results 2Mindray Medical International Announces Second Quarter 2008 Results 3Mindray Medical International Announces Second Quarter 2008 Results 4Mindray Medical International Announces Second Quarter 2008 Results 5Mindray Medical International Announces Second Quarter 2008 Results 6Mindray Medical International Announces Second Quarter 2008 Results 7Mindray Medical International Announces Second Quarter 2008 Results 8Mindray Medical International Announces Second Quarter 2008 Results 9Mindray Medical International Announces Second Quarter 2008 Results 10Mindray Medical International Announces Second Quarter 2008 Results 11Mindray Medical International Announces Second Quarter 2008 Results 12Mindray Medical International Announces Second Quarter 2008 Results 13Mindray Medical International Announces Second Quarter 2008 Results 14Mindray Medical International Announces Second Quarter 2008 Results 15Mindray Medical International Announces Second Quarter 2008 Results 16Mindray Medical International Announces Second Quarter 2008 Results 17
... Nettles Cory Nettles, secretary of Wisconsins De... resign from his post on December 31 to become a p...office. , ,Nettles has served in Governor Jim Doy...rning to the firm he worked at before Doyle appoin...nor Doyle as a leader, a boss, and a friend, he sa...
...children, December is full of excitement and antic...g. For me, December is equally exciting, as I scre...ace at February,s DEMO@15 show. While you have t... so companies that will debut at the show, there a...til the conference gems we can unwrap now. , ,One...
...ou havent ever read the opening passages of Alice...d, in 1865, to write a pretty accurate description...rabbit rushing by, very late for a very important ...n of the rabbit hole or opportunity, and unavailab...g, almost hallucinogenic quality of a workload rus...
...on, Wis. Recently UW researchers have put enough...ad spin, addressed shockwaves in fusion reactors w... hungry. Interested? Read on. , Monitor predicts e... monitor on a bicycle, add devices that measure th...ythm created by their peddling, record it all at t...
Other Biology Technology:Secretary Nettles leaving Commerce for law practice 2Secretary Nettles leaving Commerce for law practice 3An early Christmas gift 2The IT drug Just say no? 2The IT drug Just say no? 3A week in UW research: fusion, racing and sleep 2A week in UW research: fusion, racing and sleep 3
(Date:9/4/2008)...pt. 4, 2008) A variety of organismsfrom bacteria...ythms, where the timing and duration of fundamenta...low them to adapt and survive, even under fluctuat...gnificant advances have been made to understand th...anslate into modifications in cellular physiology ...
(Date:9/4/2008)... German . , Cystic kidney disease, renal fibros...excretory organs are characterized by overproducti...proteins in the renal cells. An international rese...DKFZ and Heidelberg University Hospitals has now d...se conditions. , The researchers introduced a g...
(Date:9/4/2008)... Breast Cancer Symposium features the latest cutti...clinical breast cancer research. This year,s meeti...ches, as well as strides being made in diagnosing ... the best advantage of the symposium,s scientific ... to visit www.sabcs.org to view the new press po...
(Date:9/4/2008)...ut aside their competitive interstate rivalry to c...ounced by Innovation Minister Gavin Jennings and N...ty Firth, today. , Scientists from the Monash I... from New South Wales will compare two different m...matic cell nuclear transfer (SCNT) and induced plu...
Breaking Biology News(10 mins):Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource 2Gaining a better understanding of kidney diseases 2Stem cell research puts interstate rivalry on hold 2GBIF making the search for biodiversity research resources easier 1464 1GBIF making the search for biodiversity research resources easier 1464 2Amarin Signs Agreement to Acquire Ester Neurosciences 2072 1Amarin Signs Agreement to Acquire Ester Neurosciences 2072 2Amarin Signs Agreement to Acquire Ester Neurosciences 2072 3Amarin Signs Agreement to Acquire Ester Neurosciences 2072 4Amarin Signs Agreement to Acquire Ester Neurosciences 2072 5Amarin Signs Agreement to Acquire Ester Neurosciences 2072 6Amarin Signs Agreement to Acquire Ester Neurosciences 2072 7Amarin Signs Agreement to Acquire Ester Neurosciences 2072 8Amarin Signs Agreement to Acquire Ester Neurosciences 2072 9Amarin Signs Agreement to Acquire Ester Neurosciences 2072 10Amarin Signs Agreement to Acquire Ester Neurosciences 2072 11Celtic Pharma Provides Update on XERECEPT 28R 29 Clinical Program 981 1Celtic Pharma Provides Update on XERECEPT 28R 29 Clinical Program 981 2Celtic Pharma Provides Update on XERECEPT 28R 29 Clinical Program 981 3Celtic Pharma Provides Update on XERECEPT 28R 29 Clinical Program 981 4World class in Systems Biology is the aim 1462 1World class in Systems Biology is the aim 1462 2World class in Systems Biology is the aim 1462 3World class in Systems Biology is the aim 1462 4
...patients with a blood disorder called polycythemia... at the University of California, San Diego (UCSD)...erative Medicine and Comprehensive Cancer Center a...irmed. , The discovery suggests that development o..., to interfere with the pathway leading to the dis...
...ient genes, scientists have for the first time rec...y "irreducibly complex" molecular system. , The re...r of biology at the University of Oregon,s Center ...published in the April 7 issue of SCIENCE. , How ...ex molecular systems ?those in which the function ...
...n groups battling global extinctions has saved one...d species. , American Bird Conservancy (ABC), Cons... of Colombia stepped in to protect the 1,600-acre ...e Santa Marta massif, on the Caribbean coast of Co... , The site is the sole breeding ground for the G...
...r and the Manchester Metropolitan University have ... of ancient spiders trapped in amber more than 30 ...ers from the Baltic (Poland) and the Dominican (Ca...e ecologies of spiders dating back to the Cenozoic...rom different parts of the world have been compare...
Other Biology News:Mutation in blood stem cells provides clues to cancer development 2Mutation in blood stem cells provides clues to cancer development 3Evolution of 'irreducible complexity' explained 2Crucial site for endangered frogs and birds saved 2Amber reveals ecology of 30 million year old spiders 2
Dr. P Set from different human fetal normal tissues are available. More organs maybe available upon request. Customers can choose any two items from the whole set, and pay 70% of the whole set pric
Self Closing Forceps
...micro-bore tubes to 1 outflow Single-cell and pat...apid (several millisecond) solution change Very s...revention , Solid construction 360, 250 and 10...ng on any micromanipulator Available in 4, 8, and...
...e versatile Promega Flipper® Racks are ideal f...s. These polypropylene racks withstand extreme tem...ezer storage. They may also be autoclaved for use ...ne side accommodates 0.5ml microcentrifuge tubes, ...
Biology Products: